Saturday, April 25, 2009

"Made in Purgatory", Or "The Most Desperate Love Triangle"? Which Is It?


This is small -- but worthy of its own post, I believe. Two national columnists, this week, ran these headlines, about the proposed Sch-Merck transaction (the second refers also to the J&J Remicade/Simponi potential for reversion of non-US distribution rights) -- do click the embedded links, in each, to read the whole articles. They are very worthy reads:

. . . ."Schering and Merck: A Match Made in Purgatory"

-- Brian Orelli, The Motley Fool. . . .

. . . ."Who is the Most Desperate in This Bizarre Love Triangle?"

-- Jim Edwards, BNET Pharma. . . .

3 comments:

Anonymous said...

now that goli is getting the nod by the FDA, i would bet we hear of J&J's interest in the merger and their rights for the compound.

http://finance.yahoo.com/news/FDA-clears-potential-apf-15029849.html?.v=5

Jim Edwards said...

Thanks once again for the pickup!
Jim Edwards

众乐 said...

cheap wow gold in obaoma.com